SCHEMBL6015585

SCHEMBL6015585

COc1cccc(-c2nnc(SCc3ccccn3)[nH]2)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
LMNA P02545 2/20 0.53
CYP1A2 P05177 5/20 0.45
CYP2C9 P11712 5/20 0.45
CYP2E1 P05181 4/20 0.45
CYP2C8 P10632 4/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2B6 P20813 4/20 0.45
CYP2C19 P33261 4/20 0.45
CYP3A4 P08684 4/20 0.45
KDM4E B2RXH2 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 4/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL645267 0.91 RAB9A (0.63) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015589 0.81 CYP1A2 (0.52) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015582 0.81 CYP1A2 (0.57) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015602 0.80 NPC1 (0.47) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL31644617 0.79 NPC1 (0.57) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL14777246 0.79 NPC1 (0.57) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015584 0.77 CYP1A2 (0.48) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015605 0.77 CYP1A2 (0.57) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL6015609 0.77 RAB9A (0.57) NPC1RAB9ALMNACYP1A2CYP2C9
SCHEMBL14907805 0.76 ALDH1A1 (0.46) NPC1RAB9AKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed